E N D
A Synthesis of (+)-FR182877, Featuring Tandem Transannular Diels-Alder Reactions Inspired by a Postulated BiogenesisDavid A. Vosburg, Christopher D. Vanderwal, and Erik J. SorensenDepartment of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037 Presented by Michael Elbaum
Dr. Erik J. Sorensen • Born and raised in upstate NY • Received B.S. in chemistry for Syracuse University • As a graduate student at UC San Diego, coauthored Classics in Total Synthesis • In 1995 received his PhD under Dr. K. C. Nicolaou • 1995-1997 was a NSF postdoc under Dr. Samuel Danishefsky at The Memorial Sloan-Kettering Cancer Center NY • In 2001 became Associate Professor at The Scripps Research Institute • Currently at Princeton Univeristy
(+)-FR182877 • Used in cancer therapy • Member of secondary metabolites that bind and stabilize cellular microtubules • Exhibits potency comparable to Taxol • - No Prior Synthesis • 12 stereo centers • Strained bridgehead alkene
Forward Synthesis Coupling C1 C19
Conclusion • Biogenetic pathways for the synthesis of complex natural products can provide insight into the synthesis • Synthesis of polyunsaturated macrocycle can undergo cyclization to form complex molecules • Diastereoselectrivity is intrinsic to the Diels-Alder cyclization